Journal of Cutaneous and Aesthetic Surgery

ORIGINAL ARTICLE
Year
: 2012  |  Volume : 5  |  Issue : 1  |  Page : 12--19

Giant epithelial malignancies (basal cell carcinoma, squamous cell carcinoma): A series of 20 tumors from a single center


Uwe Wollina1, Yousef Bayyoud2, Claudia Krönert1, Andreas Nowak3 
1 Department of Dermatology and Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, Dresden, Germany
2 Neurosurgical Unit, Department of Emergency and Reconstructive Surgery, Academic Teaching Hospital Dresden-Friedrichstadt, Dresden, Germany
3 Department of Anaesthesiology and Intensive Medical Care, Emergency Medicine and Pain Management, Academic Teaching Hospital Dresden-Friedrichstadt, Dresden, Germany

Correspondence Address:
Uwe Wollina
Department of Dermatology and Allergology, Academic Teaching Hospital Dresden-Friedrichstadt, Friedrichstrasse 41, 01067 Dresden
Germany

Background: Among nonmelanoma skin cancer (NMSC), basal cell carcinoma (BCC), and squamous cell carcinoma (SCC) are the most common. Giant NMSCs have occasionally reported in the medical literature with particular problems related to diagnosis and treatment. The aim of this study was to analyze patients, treatment, and outcome with giant BCC/SCC. Materials and Methods: We analyzed our files between January 1, 2008, and December 31, 2011, of an academic teaching hospital in the dermatology department. Patients were analyzed according to demographic factors, clinical presentation, histopathology, treatment, and outcome. American Society of Anesthesiology physical status system was used to assess the fitness of patients before surgery. Results: The frequency of giant NMSC was estimated as 0.4% for both tumor entities. 80% of giant BCC patients were female and 100% of giant SCC patients were male. The mean age was 81.5 ± 8.5 years for BCC) and 79.5 ± 11.4 years for SCC. The major anatomical site was the scalp. Four of 10 BCCs were classified metatypic (basosquamous). Perineural infiltration was seen in 5 NMSCs. Seventy percent of patients had an ASA score ≥3. Surgery was performed in general anaesthesia in 5 (BCC) and 6 (SCC) patients, respectively. All other patients were operated in local or tumescence anesthesia. Blood transfusions were necessary in five patients. The primary treatment was delayed Mohs technique. Defect closure was realized with rotational flaps in most cases. Neoadjuvant chemoimmune therapy and adjuvant combined cetuximab/radiotherapy have been performed in three patients. We observed three deaths, all unrelated to NMSC. 75% of patients achieved complete remission. Conclusions: Giant NMSC is uncommon but not rare. These tumors are high-risk subtypes. Treatment needs an interdisciplinary approach.


How to cite this article:
Wollina U, Bayyoud Y, Krönert C, Nowak A. Giant epithelial malignancies (basal cell carcinoma, squamous cell carcinoma): A series of 20 tumors from a single center.J Cutan Aesthet Surg 2012;5:12-19


How to cite this URL:
Wollina U, Bayyoud Y, Krönert C, Nowak A. Giant epithelial malignancies (basal cell carcinoma, squamous cell carcinoma): A series of 20 tumors from a single center. J Cutan Aesthet Surg [serial online] 2012 [cited 2020 Aug 3 ];5:12-19
Available from: http://www.jcasonline.com/article.asp?issn=0974-2077;year=2012;volume=5;issue=1;spage=12;epage=19;aulast=Wollina;type=0